Literature DB >> 19155177

Synthesis and evaluation of ligands for D2-like receptors: the role of common pharmacophoric groups.

Donald M N Sikazwe1, Nancy T Nkansah, Ramazan Altundas, Xue Y Zhu, Bryan L Roth, Vincent Setola, Seth Y Ablordeppey.   

Abstract

Arylcycloalkylamines, such as phenyl piperidines and piperazines and their arylalkyl substituents, constitute pharmacophoric groups exemplified in several antipsychotic agents. A review of previous reports indicates that arylalkyl substituents can improve the potency and selectivity of the binding affinity at D(2)-like receptors. In this paper, we explored the contributions of two key pharmacophoric groups, that is, 4'-fluorobutyrophenones and 3-methyl-7-azaindoles, to the potency and selectivity of synthesized agents at D(2)-like receptors. Preliminary observation of binding affinities indicates that there is little predictability of specific effects of the arylalkyl moieties but the composite structure is responsible for selectivity and potency at these receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19155177      PMCID: PMC2719767          DOI: 10.1016/j.bmc.2008.12.054

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  27 in total

1.  Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like species.

Authors:  M Lyles-Eggleston; R Altundas; J Xia; D M N Sikazwe; P Fan; Q Yang; S Li; W Zhang; X Zhu; A W Schmidt; M Vanase-Frawley; A Shrihkande; A Villalobos; R F Borne; S Y Ablordeppey
Journal:  J Med Chem       Date:  2004-01-29       Impact factor: 7.446

Review 2.  Role of dopamine D3 receptors in the addictive properties of ethanol.

Authors:  Christian A Heidbreder; Michela Andreoli; Clara Marcon; Panayotis K Thanos; Charles R Ashby; Eliot L Gardner
Journal:  Drugs Today (Barc)       Date:  2004-04       Impact factor: 2.245

Review 3.  Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia.

Authors:  Bryan L Roth; Douglas J Sheffler; Wesley K Kroeze
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

4.  Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning.

Authors:  Andrew O Stewart; Marlon D Cowart; Robert B Moreland; Steve P Latshaw; Mark A Matulenko; Pramila A Bhatia; Xueqing Wang; Jerome F Daanen; Sherry L Nelson; Marc A Terranova; Marian T Namovic; Diana L Donnelly-Roberts; Loan N Miller; Masaki Nakane; James P Sullivan; Jorge D Brioni
Journal:  J Med Chem       Date:  2004-04-22       Impact factor: 7.446

5.  Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats.

Authors:  Jorge D Brioni; Robert B Moreland; Marlon Cowart; Gin C Hsieh; Andrew O Stewart; Petter Hedlund; Diana L Donnelly-Roberts; Masaki Nakane; James J Lynch; Teodozyi Kolasa; James S Polakowski; Mark A Osinski; Kennan Marsh; Karl-Erik Andersson; James P Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-15       Impact factor: 11.205

6.  The acute EPS of haloperidol may be unrelated to its metabolic transformation to BCPP+.

Authors:  Donald M N Sikazwe; Shouming Li; Margaret Lyles-Eggleston; Seth Y Ablordeppey
Journal:  Bioorg Med Chem Lett       Date:  2003-11-03       Impact factor: 2.823

7.  Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine.

Authors:  Gin C Hsieh; Peter R Hollingsworth; Brenda Martino; Renjie Chang; Marc A Terranova; Alyssa B O'Neill; James J Lynch; Robert B Moreland; Diana L Donnelly-Roberts; Teodozyi Kolasa; Joseph P Mikusa; Jill M McVey; Kennan C Marsh; James P Sullivan; Jorge D Brioni
Journal:  J Pharmacol Exp Ther       Date:  2003-10-20       Impact factor: 4.030

8.  Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.

Authors:  Seth Y Ablordeppey; Ramazan Altundas; Barbara Bricker; Xue Y Zhu; Eyunni V K Suresh Kumar; Tanise Jackson; Abdul Khan; Bryan L Roth
Journal:  Bioorg Med Chem       Date:  2008-06-20       Impact factor: 3.641

9.  The novel dopamine D4 receptor agonist (PD 168,077 maleate): doses with different effects on locomotor activity are without effect in classical conditioning.

Authors:  Sahana Nayak; Helen J Cassaday
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-05       Impact factor: 5.067

10.  The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.

Authors:  M E Avale; T L Falzone; D M Gelman; M J Low; D K Grandy; M Rubinstein
Journal:  Mol Psychiatry       Date:  2004-07       Impact factor: 15.992

View more
  6 in total

1.  Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.

Authors:  Kwakye Peprah; Xue Y Zhu; Suresh V K Eyunni; Vincent Setola; Bryan L Roth; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2011-12-22       Impact factor: 3.641

2.  Enhancing a CH-π Interaction to Increase the Affinity for 5-HT1A Receptors.

Authors:  Jean-François Liégeois; Marc Lespagnard; Elsa Meneses Salas; Floriane Mangin; Jacqueline Scuvée-Moreau; Sébastien Dilly
Journal:  ACS Med Chem Lett       Date:  2014-01-29       Impact factor: 4.345

3.  Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.

Authors:  Kwakye Peprah; Xue Y Zhu; Suresh V K Eyunni; Jagan R Etukala; Vincent Setola; Bryan L Roth; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2012-01-21       Impact factor: 3.641

4.  Identification of a new selective dopamine D4 receptor ligand.

Authors:  Dinithia Sampson; Xue Y Zhu; Suresh V K Eyunni; Jagan R Etukala; Edward Ofori; Barbara Bricker; Nazarius S Lamango; Vincent Setola; Bryan L Roth; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2014-04-20       Impact factor: 3.641

5.  Further evaluation of the tropane analogs of haloperidol.

Authors:  Dinithia Sampson; Barbara Bricker; Xue Y Zhu; Kwakye Peprah; Nazarius S Lamango; Vincent Setola; Bryan L Roth; Seth Y Ablordeppey
Journal:  Bioorg Med Chem Lett       Date:  2014-07-14       Impact factor: 2.823

Review 6.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.